Using U.S. Patent Filings as a Strategic Growth Lever

For French innovators expanding into the United States, it is essential to remember that intellectual property rights secured in France or Europe do not automatically apply in the U.S. Protecting IP therefore requires early anticipation and dedicated U.S. filings, ideally before entering the market. The U.S. patent system offers more than legal protection: it can be a strategic asset. Well-timed patent filings can speed up market entry, strengthen valuation, and increase leverage in partnerships or negotiations, often in ways that differ from European practices, and are especially valuable for companies operating or scaling in the U.S.

Protecting Innovation While Testing the Market

In France and before the European Patent Office (EPO), patent protection is based on absolute novelty: once an invention is publicly disclosed, patent rights are generally lost. The U.S. system offers more flexibility, allowing companies to file a patent application within 12 months after public disclosure, sale, or use. This grace period gives French companies room to present at U.S. trade shows, meet potential partners, or test products on the market without immediately giving up their patent rights in the United States. It offers a practical way to balance innovation protection with early commercial and investor discussions.

Accelerating Patent Issuance for Early Leverage

Much like the EPO and France, a patent issuing from the U.S. Patent and Trademark Office (USPTO) can take up to two to three years to issue. However, the USPTO offers an expedited program that can reduce this time to as little as 7-12 months. Faster issuance means enforceable rights sooner, which can be a significant advantage in licensing, partnerships, or fundraising. Moreover, an issued U.S. patent can serve as credible validation of technology and significantly enhance investor confidence. Because this accelerated examination applies only to U.S. filings, French innovators may choose to file directly with the USPTO after securing the necessary Institut National de la Propriété Industrielle (INPI) foreign filing authorization.

Broadening Claim Scope and Maintaining Flexibility

The U.S. patent system generally offers greater flexibility than the EPO when it comes to claim drafting. U.S. examiners are more open to broader claims, including functional language and implicit support, allowing innovative concepts to be protected even when similar claims would be rejected in Europe. By contrast, EPO examination is stricter, requiring claims to closely mirror the original disclosure and limiting the use of generalized or functional language. As a result, patent claims granted in the United States are often broader than their European counterparts. The U.S. system also allows companies to adapt their patent strategy over time. Through continuation applications, French companies can build on an initial filing and adjust the scope of their claims as technologies evolve or market needs change. This flexibility, which does not exist under the EPO framework, makes U.S. patents a particularly strategic tool when entering or scaling in the American market.

This blog post is based on an article from the February 2026 issue of the French-American Chamber of Commerce, Texas, business magazine. Prepared by U.S. patent attorney Mark Tidwell of Haynes Boone LLP.